Trial Profile
Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 17 Feb 2016
Price :
$35
*
At a glance
- Drugs Silodosin (Primary)
- Indications Renal calculi; Ureteral calculi
- Focus Therapeutic Use
- Acronyms SiloMET
- 10 Feb 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 19 Nov 2015 Planned End Date changed from 1 Oct 2015 to 1 Oct 2016 as reported by ClinicalTrials.gov record
- 19 Nov 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Aug 2016 as reported by ClinicalTrials.gov record